<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03849326</url>
  </required_header>
  <id_info>
    <org_study_id>18CH175</org_study_id>
    <secondary_id>2018-A03511-54</secondary_id>
    <nct_id>NCT03849326</nct_id>
  </id_info>
  <brief_title>Chronic Fatigue Etiology in Intensive Care Unit Survivors: the Role of Neuromuscular Function</brief_title>
  <acronym>FatPostRéa</acronym>
  <official_title>Chronic Fatigue Etiology in Intensive Care Unit Survivors: the Role of Neuromuscular Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Saint-Etienne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic fatigue is the most common and debilitating symptom in intensive care unit (ICU)
      survivors. Indeed, it has been widely reported that patients who stayed in ICU for prolonged
      periods report a feeling of tiredness for months to years after ICU discharge. This chronic
      fatigue affects their quality of life by decreasing their capacity to perform simple tasks of
      daily life.

      The aim of the present project is to determine whether deteriorated neuromuscular function
      (i.e. increased fatigability) is involved in this feeling of chronic fatigue. Because the
      causes of this feeling are multi-dimensional, a large battery of tests will allow us to
      better understand the origin of chronic fatigue. A better knowledge of chronic fatigue
      etiology will allow to optimize rehabilitation treatments to decrease the
      apparition/persistence of chronic fatigue and in fine improve life quality.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2020</start_date>
  <completion_date type="Anticipated">April 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>voluntary maximum force reduction</measure>
    <time_frame>at 2 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neuromuscular function : cortical activity</measure>
    <time_frame>at 2 weeks</time_frame>
    <description>Level of cortical activation and cortico-spinal excitability measured by transcranial magnetic stimulation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neuromuscular function : Peripheral function</measure>
    <time_frame>at visit 2</time_frame>
    <description>Peripheral function by electrical nerve stimulation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximal oxygen uptake (VO2max)</measure>
    <time_frame>at 2 weeks</time_frame>
    <description>measured by effort test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of sleep</measure>
    <time_frame>at baseline</time_frame>
    <description>measured by actigraphy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quadriceps muscle volume (optional)</measure>
    <time_frame>at 3 weeks</time_frame>
    <description>with Magnetic resonance imaging</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>muscle dysfunction (optional)</measure>
    <time_frame>at 3 weeks</time_frame>
    <description>measured by a Phosphorus 31 Nuclear magnetic resonance test</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Chronic Fatigue Syndrome</condition>
  <condition>Intensive Care Unit</condition>
  <condition>Muscle</condition>
  <arm_group>
    <arm_group_label>&quot;Non-fatigued&quot; patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>&quot;Fatigued&quot; patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaires</intervention_name>
    <description>Quality of life Depression Physical pain Social provisions Quality of sleep</description>
    <arm_group_label>&quot;Fatigued&quot; patients</arm_group_label>
    <arm_group_label>&quot;Non-fatigued&quot; patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>blood test</intervention_name>
    <description>complete blood count and cytokine concentration</description>
    <arm_group_label>&quot;Fatigued&quot; patients</arm_group_label>
    <arm_group_label>&quot;Non-fatigued&quot; patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Maximal effort test</intervention_name>
    <description>The maximal effort test with VO2max recordings will be assessed during the first visit to the laboratory.</description>
    <arm_group_label>&quot;Fatigued&quot; patients</arm_group_label>
    <arm_group_label>&quot;Non-fatigued&quot; patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>actigraphy</intervention_name>
    <description>assessment of sleep quality</description>
    <arm_group_label>&quot;Fatigued&quot; patients</arm_group_label>
    <arm_group_label>&quot;Non-fatigued&quot; patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Neuromuscular evaluation</intervention_name>
    <description>The maximum isometric force produced by the knee extensors will be measured on the ergometer
the intensity of muscular electrical activity recorded by surface electromyography
Peripheral nerve stimulation
Transcranial magnetic stimulation
Magnetic resonance imaging (optional)</description>
    <arm_group_label>&quot;Fatigued&quot; patients</arm_group_label>
    <arm_group_label>&quot;Non-fatigued&quot; patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have been ventilated for at least 72 hours in the intensive care unit

          -  IGS2 score (severity in resuscitation) &gt; 15

          -  FACIT-F (Functional Assessment of Chronic Illness Therapy-Fatigue) score ≥ 36 or a
             score ≤ 32

          -  intensive care unit discharge in ≥ 6 months and ≤ 5 years preceding the study

          -  Approval received from a physician

          -  Command of the French language

        Exclusion Criteria:

          -  Taking neuroactive substances that can alter corticospinal excitability

          -  Contraindication to the application of a magnetic field

          -  Contraindication to the practice of Magnetic Resonance Imaging

          -  Participant is pregnant

          -  Patients with psychiatric disorders

          -  Paraplegic and hemiplegic patients

          -  Addictive disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jérome MOREL, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Saint Etienne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jérome MOREL, MD PhD</last_name>
    <phone>0477828553</phone>
    <phone_ext>+33</phone_ext>
    <email>jerome.morel@chu-st-etienne.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chu Saint-Etienne</name>
      <address>
        <city>Saint Etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Jérome MOREL, MD PhD</last_name>
      <phone>(0)477828553</phone>
      <phone_ext>+33</phone_ext>
      <email>jerome.morel@chu-st-etienne.fr</email>
    </contact>
    <investigator>
      <last_name>Pierre CROISILLE, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Léonard FEASSON, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jérôme MOREL, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital privé de la Loire</name>
      <address>
        <city>Saint-Étienne</city>
        <zip>42000</zip>
        <country>France</country>
      </address>
    </facility>
    <investigator>
      <last_name>Laurent GERGELE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>February 19, 2019</study_first_submitted>
  <study_first_submitted_qc>February 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 21, 2019</study_first_posted>
  <last_update_submitted>June 8, 2020</last_update_submitted>
  <last_update_submitted_qc>June 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neuromuscular function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatigue Syndrome, Chronic</mesh_term>
    <mesh_term>Fatigue</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

